PBA
MRUS

Paradigm Biocapital Advisors’s Merus MRUS Stock Holding History

Paradigm Biocapital Advisors’s Portfolio MRUS Stock Details MRUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,373,770
Closed -$412M – 41
2025
Q3 		$412M Buy
4,373,770
+91,816
+2% +$5.98M 11.71% 2
2025
Q2 		$225M Buy
4,281,954
+912,255
+27% +$42.9M 9.62% 3
2025
Q1 		$142M Buy
3,369,699
+1,679,777
+99% +$73.2M 6.5% 5
2024
Q4 		$71.1M Sell
1,689,922
-764,995
-31% -$36.7M 2.47% 13
2024
Q3 		$123M Buy
2,454,917
+435,103
+22% +$22.7M 4.15% 6
2024
Q2 		$120M Buy
+2,019,814
New +$97.8M 4.57% 7
2022
Q4 		– Sell
-564,214
Closed -$11.3M – 28
2022
Q3 		$11.3M Buy
564,214
+111,970
+25% +$2.67M 1.51% 21
2022
Q2 		$10.2M Buy
452,244
+202,506
+81% +$4.23M 2.04% 14
2022
Q1 		$6.6M Buy
+249,738
New +$6.69M 1.75% 20

Other funds holding MRUS

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Paradigm Biocapital Advisors's MRUS Position: Q4 2025 in Review

Paradigm Biocapital Advisors sold out of Merus (MRUS) in Q4 2025, closing a stake of 4,373,770 shares — an estimated $412M sold.

Paradigm Biocapital Advisors first reported a position in MRUS in Q1 2022 and held it in 9 quarters. The position peaked at $412M in Q3 2025. 10 funds tracked by Wall St. Rank hold MRUS as of Q4 2025.

  • Paradigm Biocapital Advisors reported no remaining Merus position as of Q4 2025 after selling out during the quarter.
  • Paradigm Biocapital Advisors sold 4,373,770 Merus shares in Q4 2025, an estimated $412M.
  • Paradigm Biocapital Advisors first reported a position in Merus in Q1 2022 and held it in 9 quarters.
  • Paradigm Biocapital Advisors's Merus position peaked at $412M in Q3 2025.
  • 10 funds tracked by Wall St. Rank held Merus as of Q4 2025.

Based on Paradigm Biocapital Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.